The use of self infused intravenous immunoglobulin home therapy in the treatment of acquired chronic demyelinating neuropathies
- Dr H M Chapel.
- Received 16 October 1996
- Revised 14 February 1997
- Accepted 3 March 1997
Abstract
High dose intravenous immunoglobulin therapy is becoming the established maintenance treatment for several neurological conditions. Therapeutic immunoglobulin is expensive and its administration is time consuming. Efficacy is variable and must be closely monitored. Here, we show that self infused immunoglobulin at home, combined with daily functional strength diaries to predict dose and dosage intervals, is effective, time saving, and convenient for both patients and medical staff.
